cagrilintide news Three new #obesity drugs—high-dose semaglutide, semaglutide plus cagrilintide, and oral orforglipron—may soon be approved in the US. JAMA Medical Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Cagrilintide - Longlife Peptides
Description
Most cite muscle cramp prevention, but the benefits go much further
But of more concern is really that it can cause receptor desensitization, maybe even turn off the whole receptor pathway
Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol
The entire experiment hinges on the purity of the peptide
